2011 ASH Program Book - American Society of Hypertension
2011 ASH Program Book - American Society of Hypertension
2011 ASH Program Book - American Society of Hypertension
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Special Lecture continued<br />
A member <strong>of</strong> several editorial boards, Dr. Epstein also serves as a<br />
reviewer for numerous prominent journals and for study sections for<br />
granting agencies.<br />
Dr. Epstein has served as the editor <strong>of</strong> 4 editions <strong>of</strong> THE KIDNEY IN<br />
LIVER DISEASE (Hanley & Belfus, Philadelphia, 1996), the premier<br />
book in the field, which surveys the wide spectrum <strong>of</strong> renal functional<br />
abnormalities in liver disease. Dr. Epstein has also co authored HYPER-<br />
TENSION: PRACTICAL MANAGEMENT (1988), which has subsequently<br />
been published in Spanish and Portuguese editions. He has also edited<br />
CALCIUM ANTAGONISTS AND THE KIDNEY (Hanley & Belfus, 1990),<br />
the first comprehensive book to survey the diverse effects <strong>of</strong> calcium<br />
antagonists on renal function, and the clinical applicability <strong>of</strong> these findings,<br />
including renal protection. Most recently, Dr. Epstein has edited<br />
3 editions <strong>of</strong> CALCIUM ANTAGONISTS IN CLINICAL MEDICINE<br />
(Hanley and Belfus, 1992, 1997, and 2002), the first comprehensive book<br />
to survey the effects <strong>of</strong> calcium antagonists on both cardiovascular and<br />
renal function. In addition, this book considers the effects <strong>of</strong> calcium<br />
antagonists on other organ systems including the management <strong>of</strong> gastrointestinal<br />
disorders, and disorders <strong>of</strong> the cerebral circulation.<br />
Dr. Epstein has also co-edited ANGIOTENSIN II RECEPTOR ANTAGO-<br />
NISTS (Hanley & Belfus 2001), the first comprehensive book to survey<br />
the effects <strong>of</strong> AT1 receptor antagonists on both cardiovascular and renal<br />
function. In addition, this book considers the effects <strong>of</strong> these novel agents<br />
in elucidating the pr<strong>of</strong>ound physiological effects <strong>of</strong> angiotensin II.<br />
Dr. Epstein, who is a 1963 graduate <strong>of</strong> Columbia University College <strong>of</strong><br />
Physicians and Surgeons, did his postgraduate medical training at University<br />
Hospital in Madison, Wisconsin and at the Cleveland MetroHealth<br />
Medical Center <strong>of</strong> Western Reserve University from 1966 to 1968, he<br />
was a Research Fellow in Nephrology in the Kidney Laboratory <strong>of</strong> Peter<br />
Bent Brigham Hospital in Boston, under Pr<strong>of</strong>essor John P. Merrill. Dr.<br />
Epstein was also an Established Investigator <strong>of</strong> the Howard Hughes<br />
Medical Institute. He is ABIM-certified in internal medicine and nephrology,<br />
and is a Fellow <strong>of</strong> both the <strong>American</strong> College <strong>of</strong> Physicians and the<br />
<strong>American</strong> <strong>Society</strong> <strong>of</strong> Nephrology. Dr Epstein has also been designated<br />
a <strong>Hypertension</strong> Specialist by the <strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Hypertension</strong>.<br />
25